Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results

OBJECTIVES: Chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and non-steroidal anti-inflammatory drug-exacerbated respiratory disease (NSAID-ERD) are frequent coexisting conditions and share type 2 inflammatory pathophysiology, with interleukin (IL)-4 and IL-13 as key cytokines. Dupilumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachert, Claus, Laidlaw, Tanya M., Cho, Seong H., Mullol, Joaquim, Swanson, Brian N., Naimi, Souad, Classe, Marion, Harel, Sivan, Jagerschmidt, Alexandre, Laws, Elizabeth, Ruddy, Marcella, Praestgaard, Amy, Amin, Nikhil, Mannent, Leda P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571440/
https://www.ncbi.nlm.nih.gov/pubmed/37322842
http://dx.doi.org/10.1177/00034894231176334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571440/
https://www.ncbi.nlm.nih.gov/pubmed/37322842
http://dx.doi.org/10.1177/00034894231176334

Ejemplares similares